Relugolix Completed Phase 2 Trials for Endometriosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01458301Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
NCT01452685A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis